| All Cemented | All Attune | All Other Cemented | PFC | Other Cemented | Attune Standard | Attune S +  |
---|---|---|---|---|---|---|---|
Total No. (BMI > 30) | 10202 | 2406 | 7796 | 4642 | 3154 | 1849 | 557 |
Total Prosthesis Years | 86,098 | 12,731 | 73,367 | 42,200 | 31,167 | 11,134 | 1598 |
Mean Follow-Up (SD) {years} | 8.4 (4.4) | 5.3 (2.3) | 9.4 (4.4) | 9.1 (4.3) | 9.88 (4.6) | 6.0 (2.1) | 2.9 (1.0) |
Range {years} | 1–20.1 | 1–11.2 | 1–20.1 | 1–19.9 | 1–20.1 | 1–11.2 | 1–4.6 |
Median (IQR) {years} | 7.8 (4.9–11.5) | 5.2 (3.5–6.9) | 9.2 (6.0–12.7) | 9.0 (5.8–12.1) | 9.5 (6.2–13.4) | 6.0 (4.6–7.6) | 3.2 (1.9–3.7) |
Female | 5922 (58%) | 1463 (61%) | 4459 (57%) | 2681 (58%) | 1778 (56%) | 1135 (61%) | 328 (59%) |
Age {years} | |||||||
  < 65 | 2933 (29%) | 694 (29%) | 2239 (29%) | 1418 (31%) | 821 (26%) | 553 (30%) | 141 (25%) |
 65–74 | 3497 (34%) | 889 (37%) | 2883 (37%) | 1668 (36%) | 1215 (39%) | 683 (37%) | 206 (37%) |
  ≥ 75 | 3772 (37%) | 823 (34%) | 2674 (34%) | 1556 (36%) | 1118 (35%) | 613 (33%) | 210 (38%) |
ASA | |||||||
 I | 891 (9%) | 143 (6%) | 748 (10%) | 354 (8%) | 394 (12%) | 127 (7%) | 16 (3%) |
 II | 7116 (70%) | 1703 (71%) | 5413 (69%) | 3311 (71%) | 2102 (667%) | 1318 (71%) | 385 (69%) |
 III | 2148 (21%) | 552 (23%) | 1596 (20%) | 957 (21%) | 639 (20%) | 397 (21%) | 155 (28%) |
 IV | 45 (< 1%) | 8 (< 1%) | 37 (< 1%) | 18 (< 1%) | 19 (< 1%) | 7 (< 1%) | 1 (< 1%) |
 V | 2 (< 1%) | 0 (< 1%) | 2 (< 1%) | 2 (< 1%) | 0 (< 1%) | 0 (0%) | 0 (0%) |
No Surgeons | 32 | 15 | 27 | 24 | 19 | 13 | 11 |
Indication | |||||||
 OA | 9955 (98%) | 2349 (98%) | 7606 (98%) | 4517 (97%) | 3089 (98%) | 1808 (98%) | 541 (97%) |
 Inflammatory Arthropathy | 187 (2%) | 42 (2%) | 145 (2%) | 95 (2%) | 50 (2%) | 31 (2%) | 11 (2%) |
 AVN | 16 (< 1%) | 3 (< 1%) | 13 (< 1%) | 10 (< 1%) | 3 (< 1%) | 1 (< 1%) | 2 (< 1%) |
 Trauma | 15 (< 1%) | 8 (< 1%) | 7 (< 1%) | 5 (< 1%) | 2 (< 1%) | 6 (< 1%) | 2 (< 1%) |
 Prev Infection | 4 (< 1%) | 1 (< 1%) | 3 (< 1%) | 3 (< 1%) | 0 (< 1%) | 1 (< 1%) | 0 (0%) |
 Other | 23 (< 1%) | 3 (< 1%) | 20 (< 1%) | 11 (< 1%) | 10 (< 1%) | 2 (< 1%) | 1 (< 1%) |
Meniscal Constraint | |||||||
 Unconstrained Mobile | 1608 (16%) | 1498 (62%) | 110 (2%) | 8 (< 1%) | 102 (3%) | 975 (53%) | 523 (94%) |
 Unconstrained Fixed | 6557 (64%) | 666 (28%) | 5891 (75%) | 3158 (68%) | 2733 (87%) | 666 (36%) | 0 (0%) |
 PS mobile | 978 (10%) | 191 (8%) | 787 (10%) | 659 (14%) | 128 (4%) | 157 (8%) | 34 (6%) |
 PS Fixed | 1059 (10%) | 51 (2%) | 1008 (13%) | 817 (18%) | 191 (6%) | 51 (3%) | 0 (0%) |